Published in Women's Health Weekly, January 13th, 2005
The international validation project was led by Transbig. The data analysis was carried out independently by a statistical team in Belgium.
The Transbig consortium intends to use the MammaPrint test in MINDACT, a large, prospective,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.